GLDM vs. NBIX
GLDM (SPDR Gold MiniShares Trust) is Gold fund tracking the LBMA Gold Price PM, while NBIX (Neurocrine Biosciences, Inc.) is a stock. Over the past 5 years, GLDM returned 17.31%/yr vs 12.34%/yr for NBIX. Their 0.02 correlation means their historical movements had little consistent relationship.
Performance
GLDM vs. NBIX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GLDM achieves a -6.13% return, which is significantly lower than NBIX's 17.61% return.
GLDM
- 1D
- -1.46%
- 1M
- 0.28%
- 6M
- -16.53%
- YTD
- -6.13%
- 1Y
- 23.01%
- 3Y*
- 27.59%
- 5Y*
- 17.31%
- 10Y*
- —
- ALL TIME*
- 15.36%
NBIX
- 1D
- -10.08%
- 1M
- -0.58%
- 6M
- 22.59%
- YTD
- 17.61%
- 1Y
- 30.08%
- 3Y*
- 17.27%
- 5Y*
- 12.34%
- 10Y*
- 12.71%
- ALL TIME*
- 9.11%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $263.44M | $251.25M | $317.77M | |
| $278.93M | $232.17M | $211.02M |
GLDM vs. NBIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
GLDM SPDR Gold MiniShares Trust | -6.13% | 64.20% | 27.08% | 13.04% | -0.47% | -4.01% | 25.10% | 18.10% | 1.75% |
NBIX Neurocrine Biosciences, Inc. | 17.61% | 3.90% | 3.60% | 10.31% | 40.24% | -11.14% | -10.83% | 50.53% | -28.30% |
Correlation
The correlation between GLDM and NBIX is 0.07, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.07 |
Correlation (3Y) Balances recent behavior with more history. | 0.05 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.03 |
Correlation (All Time) Calculated using the full available price history since Jun 26, 2018 | 0.02 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GLDM vs. NBIX — Risk / Return Rank
GLDM
NBIX
GLDM vs. NBIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR Gold MiniShares Trust (GLDM) and Neurocrine Biosciences, Inc. (NBIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GLDM | NBIX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.08 | ||
| Sortino ratioReturn per unit of downside risk | -0.19 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.19 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 0.88 | 1.45 | -0.57 |
| Martin ratioReturn relative to average drawdown | 1.90 | 3.18 | -1.28 |
Loading charts...
Drawdowns
GLDM vs. NBIX - Drawdown Comparison
The maximum GLDM drawdown since its inception was -26.27%, smaller than the maximum NBIX drawdown of -97.21%. Use the drawdown chart below to compare losses from any high point for GLDM and NBIX.
Loading charts...
Drawdown Indicators
| GLDM | NBIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -26.27% | -97.21% | +70.94% |
Max Drawdown (1Y)Largest decline over 1 year | -26.27% | -20.90% | -5.37% |
Max Drawdown (3Y)Largest decline over 3 years | -26.27% | -42.89% | +16.62% |
Max Drawdown (5Y)Largest decline over 5 years | -26.27% | -42.89% | +16.62% |
Max Drawdown (10Y)Largest decline over 10 years | — | -46.39% | — |
Current DrawdownCurrent decline from peak | -24.94% | -10.08% | -14.86% |
Average DrawdownAverage peak-to-trough decline | -6.56% | -43.66% | +37.10% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.12% | 9.47% | +2.65% |
Volatility
GLDM vs. NBIX - Volatility Comparison
The current volatility for SPDR Gold MiniShares Trust (GLDM) is 6.35%, while Neurocrine Biosciences, Inc. (NBIX) has a volatility of 14.12%. This indicates that GLDM experiences smaller price fluctuations and is considered to be less risky than NBIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GLDM | NBIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.35% | 14.12% | -7.77% |
Volatility (6M)Calculated over the trailing 6-month period | 23.37% | 26.01% | -2.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.92% | 33.74% | -5.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.39% | 33.17% | -14.78% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.10% | 39.18% | -22.08% |
Dividends
GLDM vs. NBIX - Dividend Comparison
Neither GLDM nor NBIX has paid dividends to shareholders.
Frequently Asked Questions
GLDM and NBIX have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NBIX has higher volatility (14.12%) compared to GLDM (6.35%). In terms of maximum drawdown, GLDM dropped -26.27% vs NBIX's -97.21%.
NBIX currently has the higher Sharpe Ratio (0.91 vs 0.83), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GLDM and NBIX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer